What We're Reading: Page 28
Industry reads hand-picked by our editors
Jan 28, 2025
-
Financial Times
Robert Kennedy allies fear he is losing US Senate support
-
The Wall Street Journal
Drugmakers Show Restraint on Price Increases in New Trump Era
-
Bloomberg
Pfizer Dodges Challenge to Its Board in Battle With Starboard
-
AP News
CDC ordered to stop working with WHO immediately
Jan 27, 2025
-
Bloomberg
Merck’s $8 Billion Cancer Vaccine Faces First US Jury Trial
-
The Wall Street Journal
Pfizer to Pay $60 Million in Kickback, False Claims Settlement
-
Financial Times
China investigates generic drugs over safety concerns
Jan 24, 2025
-
Semafor
Pfizer CEO Albert Bourla on Trump and the coming collapse of the status quo
-
The New York Times
ExThera Claimed Its Device Could Cure Cancer. But Patients Died.
-
Nature News
What went wrong at 23andMe? Why the genetic-data giant risks collapse
-
Reuters
WHO chief to cut costs, reset priorities after US exit, document shows
Jan 23, 2025
Jan 22, 2025
Jan 21, 2025
-
The Wall Street Journal
Beaten Down Under Biden, Big Pharma Hopes for New Chapter Under Trump
-
Bloomberg Law
Biogen Sued by Neuroscience Company Sage After Buyout Offer
-
Nature News
Trump’s science advisers: how they could influence his second presidency
Previous
